Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

January will test your resilience, push you to confront your inner demons and face the darker aspects of your life you've ...

A recommended warning against alcohol use by the U.S. surgeon general may boost the fortune of cannabis companies - and could lead to some alcohol companies diversifying by adding cannabis to their ...

Alcohol giants have a hazy future. Late last week, the U.S. surgeon general said beer and spirits cause cancer and should ...

Alcohol companies like Heineken, Constellation Brands, and AB InBev have been preparing for a customer culture shift toward ...

The Dogs of the Dow 2025 pay big dividends—up to 6.8%! Collectively they yield three-times what the broader market pays.

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

U.S. stock futures were little changed Thursday night after a volatile start to the new year. Dow Jones Industrial Average ...

Patients with liver tumors that meet the following may be candidates: The tumor is less than 4 centimeters in size Have three or fewer tumors The tumor is in a favorable location for treatment Talk to ...

2025 is a year of transformation—and it all starts with some big planetary shifts in January, which will prove once and for ...

While there’s excitement ahead, these 4 zodiac signs are set to enjoy luck and abundance in this new year 2025.